MoonLake Immunotherapeutics MLTX Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's operating lease liability - undiscounted excess amount?
- MoonLake Immunotherapeutics (MLTX) reported operating lease liability - undiscounted excess amount of $133K in Q1 2026.
- How has MoonLake Immunotherapeutics's operating lease liability - undiscounted excess amount changed year-over-year?
- MoonLake Immunotherapeutics's operating lease liability - undiscounted excess amount increased by 8.1% year-over-year, from $123K to $133K.
- What does operating lease liability - undiscounted excess amount mean?
- This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.